<DOC>
	<DOCNO>NCT01654250</DOCNO>
	<brief_summary>The safety efficacy chewable formulation extended-release methylphenidate study child ADHD</brief_summary>
	<brief_title>NWP09 Children With Attention Deficit Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Children age 6 12 year ADHD require pharmacologic treatment condition Other serious illness condition would put patient particular risk safety event would interfere treatment/assessment ADHD</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>ADHD</keyword>
	<keyword>methylphenidate extended-release</keyword>
</DOC>